Home › NDC Lookup › RxCUI directory › RxCUI 905034

Risedronate sodium 30 MG Oral Tablet [Actonel] — RxCUI 905034

RxNorm drug concept · Semantic branded drug
RxCUI 905034 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI905034
Official nameRisedronate sodium 30 MG Oral Tablet [Actonel]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asActonel 30 MG Oral Tablet
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Risedronate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It helps strengthen bones. Depending on the product, it treats or prevents osteoporosis in postmenopausal women, treats osteoporosis in men, treats or prevents steroid-related oste...
  • Regular tablets go down whole with a full glass of plain water at least 30 minutes before food, drink or other medicines. Delayed-release tablets are taken right after breakfast wi...
  • Back pain, joint pain, belly pain and indigestion are the most common. Call your doctor if you have painful swallowing, chest pain, new heartburn, severe bone or muscle pain, or ne...
  • Not at the same time. Calcium, antacids, magnesium products and iron can block absorption, so take them at a different time of day. Do get enough calcium and vitamin D, as your doc...
📖 Read our full Risedronate guide →

🕸️ Concept Web — How Risedronate sodium 30 MG Oral Tablet [Actonel] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Risedronate sodium 30 MG Oral Tablet [Actonel] RxCUI 905034

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Risedronate 73056
    • Risedronate sodium 60334
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Actonel 753143
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Risedronate Oral Tablet 617278
    • Risedronate sodium Oral Tablet 2648069
    • Risedronate Oral Product 1165476
    • Risedronate Pill 1165477
    • Risedronate sodium Oral Product 2659877
    • Risedronate sodium Pill 2661515
    • Risedronate Oral Tablet [Actonel] 753145
    • Risedronate sodium Oral Tablet [Actonel] 2657670
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Risedronate sodium 30 MG Oral Tablet SCD · 905032
  • Risedronate sodium 30 MG SCDC · 905031
  • Risedronate Oral Tablet SCDF · 617278
  • Risedronate sodium Oral Tablet SCDFP · 2648069
  • Risedronate Oral Product SCDG · 1165476
  • Risedronate Pill SCDG · 1165477
  • Risedronate sodium Oral Product SCDGP · 2659877
  • Risedronate sodium Pill SCDGP · 2661515

Brand-Name Concepts

  • Risedronate sodium 30 MG [Actonel] SBDC · 905033
  • Risedronate Oral Tablet [Actonel] SBDF · 753145
  • Risedronate sodium Oral Tablet [Actonel] SBDFP · 2657670
  • Actonel Oral Product SBDG · 1169918
  • Actonel Pill SBDG · 1169919
  • Actonel BN · 753143

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 905034 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00430-0472-03 4 TABLET, FILM COATED in 1 DOSE PACK (0430-0472-03) Actonel Allergan, Inc. 2002-05-17
00430-0478-01 1 TABLET, FILM COATED in 1 DOSE PACK (0430-0478-01) Actonel Allergan, Inc. 2008-04-22
Observed labelers: Allergan, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.